“Muscular degeneration” is one of the most commonly searched health terms, but it actually blends two separate conditions. Most people searching this phrase are looking for macular degeneration, an eye disease that gradually destroys central vision. Others mean literal muscle degeneration, the progressive loss of muscle mass and strength. Both conditions become more common with age, and both benefit from early action. Here’s what you need to know about each.
Macular Degeneration: The Eye Condition
Age-related macular degeneration (AMD) damages the macula, a small area at the center of your retina responsible for sharp, straight-ahead vision. It’s the leading cause of vision loss in adults over 50. You might first notice that straight lines look wavy, or that a blurry spot appears in the center of your visual field while your peripheral vision stays intact.
AMD comes in two forms: dry and wet. About 80% of cases are the dry type, which develops when tiny protein deposits called drusen accumulate in the macula and slowly break down the light-sensitive cells there. Vision loss with dry AMD tends to progress gradually over years. Wet AMD is less common but more aggressive. It occurs when abnormal blood vessels grow beneath the retina in the macular region, leaking fluid and blood that cause swelling and rapid damage to central vision.
How Macular Degeneration Is Detected
One of the earliest signs of AMD is metamorphopsia, where straight lines appear bent or distorted. Eye doctors often screen for this with a tool called an Amsler grid: a simple card with a pattern of horizontal and vertical lines forming 400 small squares. You focus on a central dot with one eye at a time, and if the lines look curved, broken, or blurred, that signals possible macular changes. The grid is a useful first step, though it catches roughly 60% of cases when compared against more advanced imaging, so a normal result doesn’t guarantee clear maculas.
For a definitive look, doctors use optical coherence tomography (OCT), which creates detailed cross-sectional images of the retina. OCT can reveal drusen deposits, fluid buildup, and abnormal blood vessel growth well before you notice significant vision changes. Regular dilated eye exams become especially important after age 50, since early-stage dry AMD often produces no symptoms at all.
Treating and Slowing AMD
There’s no cure for dry AMD, but a specific supplement formula developed through a large clinical trial (AREDS2) has been shown to slow progression in people with intermediate or advanced dry AMD. The formula contains 500 mg of vitamin C, 400 IU of vitamin E, 10 mg of lutein, 2 mg of zeaxanthin, and 80 mg of zinc. These aren’t general multivitamins. They’re specifically dosed for macular protection, and your eye doctor can tell you whether you’re at the stage where they’d help.
Wet AMD is treated with injections that block a protein responsible for abnormal blood vessel growth. These injections go directly into the eye, which sounds alarming, but the procedure is quick and the eye is numbed beforehand. Treatment typically starts with monthly injections until the fluid dries up, then shifts to a “treat and extend” approach where the interval between injections gradually stretches to every 8 to 12 weeks. If fluid returns, the schedule tightens again. Most people maintain or improve their vision with consistent treatment, but stopping too early often leads to relapse.
Muscle Degeneration: Sarcopenia
If you’re searching about actual muscle loss rather than the eye condition, the medical term is sarcopenia. After about age 50, muscle mass decreases at a rate of 1 to 2% per year. That might sound small, but it compounds. By your 70s, you may have lost 20 to 40% of the muscle you had at your peak, and the strength losses are even steeper because the muscle fibers that shrink fastest are the type II fibers responsible for power and quick movements.
Several biological shifts drive this process. Your body becomes less responsive to the signals that normally trigger muscle building, a phenomenon called anabolic resistance. Essentially, aging muscles need more protein and more exercise stimulus to maintain themselves than younger muscles do. At the same time, testosterone, growth hormone, and other muscle-supporting hormones decline, while cortisol (a stress hormone that breaks down tissue) tends to rise. Fat also infiltrates the muscle tissue itself, reducing its quality even when overall body weight stays stable. The pool of satellite cells, which are the repair crews that fix damaged muscle fibers, shrinks with age, making recovery from injury slower and less complete.
Preventing and Managing Muscle Loss
Resistance training is the single most effective intervention for sarcopenia. Lifting weights, using resistance bands, or doing bodyweight exercises two to three times per week directly counteracts the loss of type II muscle fibers. Even people in their 80s and 90s can build measurable strength with consistent training.
Protein intake matters more as you age, precisely because of anabolic resistance. Older adults need a greater quantity of amino acids to achieve maximum stimulation of muscle protein synthesis compared to younger people. Current evidence suggests older adults should aim for 1.2 to 2.0 grams of protein per kilogram of body weight per day, depending on health status. For someone who weighs 70 kg (about 154 pounds), that’s roughly 85 to 140 grams of protein daily. People who already have sarcopenia need about 30% more protein than healthy older adults to maintain muscle. Spreading protein intake across meals rather than loading it into dinner appears to be more effective for muscle maintenance.
Muscular Dystrophy: A Different Condition
Muscular dystrophy is sometimes confused with age-related muscle loss, but it’s a distinct group of genetic disorders that cause progressive muscle weakness. Unlike sarcopenia, muscular dystrophy is inherited and often appears much earlier in life. There are at least nine major types, each caused by different gene mutations.
Duchenne muscular dystrophy, the most severe form, typically shows symptoms before age 5 and primarily affects boys. Becker muscular dystrophy involves the same gene but progresses more slowly, with symptoms sometimes not appearing until adulthood. Myotonic dystrophy, the most common adult-onset form, usually begins between ages 10 and 30. Other types include limb-girdle (onset varies from childhood to adulthood), facioscapulohumeral (young adulthood), congenital (present at birth), distal (adulthood), oculopharyngeal (after age 40), and Emery-Dreifuss (childhood).
The unifying feature across all types is that the genetic defect disrupts proteins essential for muscle structure or function, leading to progressive weakness that worsens over time. Treatment focuses on maintaining mobility and function for as long as possible through physical therapy, assistive devices, and in some cases medications that slow disease progression.